FDA Approves First Generic Capecitabine to Treat Colorectal and Breast Cancers
The US Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.
Cancer Stats Don’t Add Up, But Numbers Do
By the time breast cancer spreads, women have usually had a number of different treatments. They may have been through more than one round of chemotherapy. A study of different chemotherapies has found somewhat puzzling results.